1. Home
  2. TSQ vs ADCT Comparison

TSQ vs ADCT Comparison

Compare TSQ & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TSQ

Townsquare Media Inc.

HOLD

Current Price

$6.29

Market Cap

117.4M

ML Signal

HOLD

Logo ADC Therapeutics SA

ADCT

ADC Therapeutics SA

HOLD

Current Price

$1.12

Market Cap

136.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSQ
ADCT
Founded
1996
2011
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
117.4M
136.1M
IPO Year
2014
2019

Fundamental Metrics

Financial Performance
Metric
TSQ
ADCT
Price
$6.29
$1.12
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$11.50
$7.75
AVG Volume (30 Days)
62.4K
878.2K
Earning Date
05-11-2026
05-04-2026
Dividend Yield
12.80%
N/A
EPS Growth
N/A
30.86
EPS
N/A
N/A
Revenue
$427,380,000.00
$81,357,000.00
Revenue This Year
$2.22
N/A
Revenue Next Year
$0.48
$66.49
P/E Ratio
$39.75
N/A
Revenue Growth
N/A
14.85
52 Week Low
$4.30
$0.78
52 Week High
$7.97
$4.98

Technical Indicators

Market Signals
Indicator
TSQ
ADCT
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
TSQ
ADCT

About TSQ Townsquare Media Inc.

Townsquare Media Inc is a radio, digital media, entertainment, and digital marketing solutions company principally focused on being the local advertising and marketing solutions platform in small and mid-sized markets across the United States. It has three segments which are Subscription Digital Marketing Solutions, Digital Advertising, and Broadcast Advertising. It earns the majority of the revenue from the Broadcasting Advertising segment, which includes its local, regional, and national advertising products and solutions delivered via terrestrial radio broadcast. Its portfolio includes local media brands such as WYRK.com, WJON.com, and NJ101.5.com, and national music brands such as XXLmag.com, TasteofCountry.com, UltimateClassicRock.com, and Loudwire.com.

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. Additionally, the company's development pipeline comprises LOTIS-2, LOTIS-5, LOTIS-7, and ADCT-241, being developed as potential therapies for different cancer diseases. Geographically, the firm generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

Share on Social Networks: